SRCL Stock Recent News

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Stericycle, Inc. (NASDAQ: SRCL) to Waste Management, Inc. for $62.00 per share in cash is fair to Stericycle shareholders. Halper Sadeh encourages Stericycle shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Ster.

SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP , a leading shareholder rights law firm, announced today that it has initiated an investigation into the board members of Stericycle (NASDAQ: SRCL) concerning potential breaches of fiduciary duties related to the proposed sale of the Company to Waste Management, Inc. (NYSE: WM).

MONSEY, N.Y., June 03, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $62.00 per share in cash for which Stericycle, Inc. (Nasdaq: SRCL) (“Stericycle”) has agreed to be sold to Waste Management, Inc. (“WMI”).

Waste Management will acquire Stericycle in a $7.2 billion deal, the companies said Monday. WM will acquire all outstanding shares of Stericycle for $62 per share in cash, representing the deal's total value when including Stericycle's net debt of around $1.4 billion.

HOUSTON & BANNOCKBURN, Ill.--(BUSINESS WIRE)---- $WM--Waste Management, Inc. (NYSE: WM) and Stericycle (NASDAQ: SRCL) announced today that they have entered into a definitive agreement under which WM will acquire all outstanding shares of Stericycle for $62.00 per share in cash, representing a total enterprise value of approximately $7.2 billion when including approximately $1.4 billion of Stericycle's net debt. The per share price represents a premium of 24% to Stericycle's 60-day volume weighted aver.

Stericycle Inc. (NASDAQ:SRCL) is in the spotlight as Waste Management Inc. (NYSE: WM) moves closer to acquiring the medical waste disposal company for $7 billion, including debt. This potential deal, reported by The Wall Street Journal on June 2nd, could be announced soon.

Waste Management is nearing a deal to buy medical-waste-disposal company Stericycle for roughly $7 billion including debt.

Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts.

SRCL's Q1 2024 operating margins beat expectations, and the company's EBITDA margin is expected to improve significantly for full-year 2024. I anticipate that Stericycle's Secure Information Destruction segment can realize a turnaround due to a more favorable base for YoY comparison in 2H and the introduction of a subscription service. My Buy rating for SRCL stays intact following an assessment of its outlook and valuations.

Stericycle (SRCL) witnesses weak segmental performance in the first quarter of 2024.